{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated with Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease (NSABP B-64)","item":"https:\/\/www.regionalcancercare.org\/trials\/breast-cancer-clinical-validation-study-to-predict-recurrence-of-high-risk-early-breast-cancer-treated-with-neoadjuvant-therapy-using-a-bespoke-circulating-tumor-dna-assay-to-detect-molecular-residual\/#breadcrumbitem"}]}